Artemis Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.2M | Sell |
72,097
-2,971
| -4% | -$2.32M | 0.72% | 44 |
|
|
2025
Q1 | $62M | Buy |
75,068
+14,758
| +24% | +$12.2M | 0.95% | 36 |
|
|
2024
Q4 | $46.6M | Buy |
60,310
+4,836
| +9% | +$3.73M | 0.66% | 52 |
|
|
2024
Q3 | $49.1M | Buy |
55,474
+12,769
| +30% | +$11.3M | 0.75% | 38 |
|
|
2024
Q2 | $38.7M | Sell |
42,705
-23,173
| -35% | -$21M | 0.52% | 59 |
|
|
2024
Q1 | $51.2M | Sell |
65,878
-745
| -1% | -$579K | 0.65% | 47 |
|
|
2023
Q4 | $38.8M | Sell |
66,623
-39,479
| -37% | -$23M | 0.56% | 57 |
|
|
2023
Q3 | $57M | Sell |
106,102
-9,689
| -8% | -$5.2M | 0.79% | 40 |
|
|
2023
Q2 | $54.2M | Buy |
+115,791
| New | +$54.2M | 0.68% | 47 |
|
|
2022
Q2 | – | Sell |
-95,026
| Closed | -$27.2M | – | 270 |
|
|
2022
Q1 | $27.2M | Buy |
+95,026
| New | +$27.2M | 0.22% | 119 |
|
|
2020
Q4 | – | Sell |
-38,214
| Closed | -$5.65M | – | 279 |
|
|
2020
Q3 | $5.65M | Sell |
38,214
-2,975
| -7% | -$440K | 0.07% | 207 |
|
|
2020
Q2 | $6.78M | Buy |
41,189
+14,271
| +53% | +$2.35M | 0.09% | 197 |
|
|
2020
Q1 | $3.73K | Buy |
+26,918
| New | +$3.73K | 0.01% | 187 |
|
|
2019
Q1 | – | Sell |
-197,851
| Closed | -$22.9M | – | 289 |
|
|
2018
Q4 | $22.9M | Sell |
197,851
-158,057
| -44% | -$18.3M | 0.3% | 101 |
|
|
2018
Q3 | $38.2M | Buy |
355,908
+98,108
| +38% | +$10.5M | 0.42% | 62 |
|
|
2018
Q2 | $22M | Buy |
+257,800
| New | +$22M | 0.3% | 87 |
|
|
2015
Q4 | – | Sell |
-135,094
| Closed | -$11.3M | – | 235 |
|
|
2015
Q3 | $11.3M | Buy |
135,094
+59,453
| +79% | +$4.97M | 0.33% | 76 |
|
|
2015
Q2 | $6.31M | Buy |
+75,641
| New | +$6.31M | 0.2% | 112 |
|